EGCG Enhances the Efficacy of Cisplatin by Downregulating hsa-miR-98-5p in NSCLC A549 Cells

Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors

(2014) Mark E. Stearns et al.   Translational Oncology

Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy

(2013) Elena Lecumberri et al.   CLINICAL NUTRITION

Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation

(2013) Huaping Chen et al.   EXPERIMENTAL CELL RESEARCH

microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn

(2013) L. Ninio-Many et al.   JOURNAL OF CELL SCIENCE

Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines

(2013) Francesca De Amicis et al.   JOURNAL OF CELLULAR PHYSIOLOGY

MicroRNAs as potential biomarkers in human solid tumors

(2012) Jun Shen et al.   CANCER LETTERS

Apoptosis and microRNA aberrations in cancer

(2012) Chun Li et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

MicroRNA and cancer

(2012) Martin D. Jansson et al.   Molecular Oncology

miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway

(2011) Shuai Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea

(2011) Bret Bannerman et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1 

(2011) H. Wang et al.   CARCINOGENESIS

Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention

(2011) H. Yang et al.   CURRENT CANCER DRUG TARGETS

Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability

(2011) Jun Ge et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases

(2011) Masahito Shimizu et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Mechanistic issues concerning cancer prevention by tea catechins

(2011) Chung S. Yang et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines

(2011) A.M. El-Mowafy et al.   NATURAL PRODUCT RESEARCH

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

(2010) Lili Jiang et al.   BMC CANCER

Chemoprevention of Head and Neck Cancer with Green Tea Polyphenols

(2010) J. W. Kim et al.   Cancer Prevention Research

New cancer treatment strategy using combination of green tea catechins and anticancer drugs

(2010) Masami Suganuma et al.   CANCER SCIENCE

mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities

(2010) H. Liu et al.   MOLECULAR CANCER THERAPEUTICS

Novel chemotherapeutic and renal protective effects for the green tea (EGCG): Role of oxidative stress and inflammatory-cytokine signaling

(2010) A.M. El-Mowafy et al.   PHYTOMEDICINE

(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line

(2010) F. Farabegoli et al.   PHYTOMEDICINE

Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation

(2009) Ozgur Kutuk et al.   CARCINOGENESIS

Cisplatin-Induced Hair Cell Death Requires STAT1 and Is Attenuated by Epigallocatechin Gallate

(2009) N. C. Schmitt et al.   JOURNAL OF NEUROSCIENCE

Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells

(2009) Wing Pui Tsang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

(2009) R. E. Lanford et al.   SCIENCE

Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells

(2008) Chih-Pin Chuu et al.   CANCER LETTERS

The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin

(2008) Amal Shervington et al.   MOLECULAR BIOLOGY REPORTS

MicroRNAs modulate the chemosensitivity of tumor cells

(2008) P. E. Blower et al.   MOLECULAR CANCER THERAPEUTICS